Gene · 634
Papers3,222
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 3,222
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mapping the developing human cardiac endothelium at single-cell resolution identifies MECOM as a regulator of arteriovenous gene expression. | Cardiovasc Res | 2022 | 35212715 | PubTator, text mining | PubMed |
| HDL-Associated Lipoproteins: Potential Prognostic Biomarkers for Gram-Negative Sepsis. | J Inflamm Res | 2022 | 35210815 | PubTator, text mining | PubMed |
| Immunotherapy for Colorectal Cancer: Mechanisms and Predictive Biomarkers. | Cancers (Basel) | 2022 | 35205776 | PubTator, text mining | PubMed |
| The Eutopic Endometrium Proteome in Endometriosis Reveals Candidate Markers and Molecular Mechanisms of Physiopathology. | Diagnostics (Basel) | 2022 | 35204508 | PubTator, text mining | PubMed |
| Harnessing Natural Killer Cells in Non-Small Cell Lung Cancer. | Cells | 2022 | 35203256 | PubTator, text mining | PubMed |
| Oncolytic adenovirus decreases the proportion of TIM-3+ subset of tumor-infiltrating CD8+ T cells with correlation to improved survival in patients with cancer. | J Immunother Cancer | 2022 | 35193929 | PubTator, text mining | PubMed |
| Implications of Using Host Response-Based Molecular Diagnostics on the Management of Bacterial and Viral Infections: A Review. | Front Med (Lausanne) | 2022 | 35186993 | PubTator, text mining | PubMed |
| More Than Just a Periodontal Pathogen -the Research Progress on Fusobacterium nucleatum. | Front Cell Infect Microbiol | 2022 | 35186795 | PubTator, text mining | PubMed |
| Unraveling the Expression Patterns of Immune Checkpoints Identifies New Subtypes and Emerging Therapeutic Indicators in Lung Adenocarcinoma. | Oxid Med Cell Longev | 2022 | 35178154 | PubTator, text mining | PubMed |
| Tumor Expression Quantitative Trait Methylation Screening Reveals Distinct CpG Panels for Deconvolving Cancer Immune Signatures. | Cancer Res | 2022 | 35176128 | PubTator, text mining | PubMed |
Identification of Key Genes Related With Aspartic Acid Metabolism and Corresponding Protein Expression in Human Colon Cancer With Postoperative Prognosis and the Underlying Molecular Pathways Prediction. | Front Cell Dev Biol | 2022 | 35174151 | PubTator, text mining | PubMed |
| Zika virus disrupts gene expression in human myoblasts and myotubes: Relationship with susceptibility to infection. | PLoS Negl Trop Dis | 2022 | 35171909 | PubTator, text mining | PubMed |
| Blockade of novel immune checkpoints and new therapeutic combinations to boost antitumor immunity. | J Exp Clin Cancer Res | 2022 | 35164813 | PubTator, text mining | PubMed |
| Pathogenesis, Diagnosis and Management of Obstetric Antiphospholipid Syndrome: A Comprehensive Review. | J Clin Med | 2022 | 35160128 | PubTator, text mining | PubMed |
| Exosomal Proteins and Lipids as Potential Biomarkers for Lung Cancer Diagnosis, Prognosis, and Treatment. | Cancers (Basel) | 2022 | 35158999 | PubTator, text mining | PubMed |
| Alternative Splicing, Epigenetic Modifications and Cancer: A Dangerous Triangle, or a Hopeful One? | Cancers (Basel) | 2022 | 35158828 | PubTator, text mining | PubMed |
| Diversity of Coronaviruses with Particular Attention to the Interspecies Transmission of SARS-CoV-2. | Animals (Basel) | 2022 | 35158701 | PubTator, text mining | PubMed |
| Single-Cell Analysis Reveals Unexpected Cellular Changes and Transposon Expression Signatures in the Colonic Epithelium of Treatment-Naïve Adult Crohn's Disease Patients. | Cell Mol Gastroenterol Hepatol | 2022 | 35158099 | PubTator, text mining | PubMed |
| Disrupting cancer angiogenesis and immune checkpoint networks for improved tumor immunity. | Semin Cancer Biol | 2022 | 35149179 | PubTator, text mining | PubMed |
| Bibliometric analysis of the 100 top-cited articles on immunotherapy of urological cancer. | Hum Vaccin Immunother | 2022 | 35148255 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/634/papers?page=43